Tyra Biosciences
Price & Volume
Stats
See more52W Range | $6.42-$29.60 |
Market Cap | $715.2M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.93 |
News
See moreYahoo Finance • 3 months ago
H.C. Wainwright reiterates Buy rating on Tyra Biosciences stock at $30
Yahoo Finance • 3 months ago
Tyra Biosciences Doses First Patient in Phase 2 Study of TYRA-300 in Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)
Yahoo Finance • 3 months ago
Tyra Biosciences begins dosing in Phase 2 trial for TYRA-300 in bladder cancer
Yahoo Finance • 2 years ago
16 Most Promising Long-Term Stocks According to Analysts
About
CEO | Dr. Todd Harris Ph.D. |
Address | 2656 State Street, Carlsbad, CA, United States, 92008 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 60 |
